ANDA 76033, held by Pharmazone. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76033 (Metformin Hydrochloride), held by Pharmazone, was first approved by FDA on Jan 24, 2002, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 24, 2002 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Rx |
| Aug 11, 2026 | Supplement 21Labeling · Standard review | Approved | None posted |
| Feb 2, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Feb 2, 2019 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 10, 2002 | Supplement 5Manufacturing | Approved | None posted |
| Oct 11, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Sep 26, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Aug 29, 2002 | Supplement 4Labeling | Approved | None posted |
| Apr 11, 2002 | Supplement 1Labeling | Approved | None posted |
| Jan 24, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters